Tehran University of Medical Sciences International Journal of Hematology-Oncology and Stem Cell Research 2008-2207 10 3 2016 06 28 191 194 EN Ali Ghorbani Abdehgah Thoracic Surgeon, Assistant Professor, Department of Surgery, Research Center for Improvement of Surgical Outcomes and Procedures, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Behnam Molavi Vascular Surgeon, Assistant Professor, Department of Surgery, Research Center for Improvement of Surgical Outcomes and Procedures, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Saeed Reza Mehrpour Orthopedic Surgeon, Assistant Professor, Department of Orthopedics, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Amir Reza Radmard Radiologist, Assistant Professor, Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Mohammad Mahjori General Surgeon, Department of Surgery, Research Center for Improvement of Surgical Outcomes and Procedures, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Nasser Kamalian Pathologist, Professor, Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Hossein Kamranzadeh Medical Oncologist, Assistant Professor, Hematology and Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran 2015 11 15 2015 12 23 Clavicular bone tumors occur in less than 0.5 percent of bone tumors. Primary chondrosarcoma is very rare even among clavicle tumors. The main symptom is a touchable mass in 69 % of patients. Dedicated centers using FNA and cytology can reach a correct diagnosis in 94% of cases. Treatment planning is done using simple X-ray, CT-scan, shoulder MRI, chest CT-scan, and whole body technetium scan. Treatment of choice for primary chondrosarcoma of clavicle is surgical resection.   https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/507 https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/507/504